Antiviral treatment and prophylaxis of influenza virus in children.
Nayak
Jennifer L
JL
Department of Pediatrics, Division of Pediatric Infectious Diseases, Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA.
Treanor
John J
JJ
D000547:Amantadine / Q000276:immunology / Q000627:therapeutic use; D000998:Antiviral Agents / Q000276:immunology / Q000627:therapeutic use*; D018890:Chemoprevention / Q000379:methods*; D002648:Child; D002675:Child, Preschool; D004791:Enzyme Inhibitors / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology; D007251:Influenza, Human / Q000175:diagnosis / Q000276:immunology / Q000517:prevention & control*; D053139:Oseltamivir / Q000276:immunology / Q000627:therapeutic use; D056990:Post-Exposure Prophylaxis / Q000379:methods*; D053243:Zanamivir / Q000276:immunology / Q000627:therapeutic use
D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D053139:Oseltamivir; D000547:Amantadine; D053243:Zanamivir